#news #biotech Lilly’s phase 2 Alzheimer’s win marred by missed secondaries, questions about clinical significance

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Lilly’s phase 2 Alzheimer’s win marred by missed secondaries, questions about clinical significance .Lilly’s phase 2 Alzheimer’s win marred by missed secondaries, questions about clinical significance
ntaylor
Mon, 03/15/2021 – 03:38

from FierceBiotech: Biotech https://ift.tt/3qHtCTa